<em>Sheila Gujrathi, Gossamer Bio’s COO, said Receptos being acquired by Celgene was fortunate, but “also kind of a letdown, because we had assembled this great team and we wanted to continue.”</em>

<em>Sheila Gujrathi, Gossamer Bio’s COO, said Receptos being acquired by Celgene was fortunate, but “also kind of a letdown, because we had assembled this great team and we wanted to continue.”</em>

— In 2015, San Diego’s Receptos sold to Celgene for $7...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • NEW: San Diego 500 — influential business leaders you need to know
Yours for only $129